How Safe Is the Use of Intradetrusor OnabotulinumtoxinA in Children?

Abstract

No AccessJournal of UrologyEditorials1 Apr 2023How Safe Is the Use of Intradetrusor OnabotulinumtoxinA in Children? Christina B. Ching Christina B. ChingChristina B. Ching *Correspondence: Nationwide Children’s Hospital, 700 Children’s Hospital Dr, Columbus, OH 43205 telephone: 614-722-6630; E-mail Address: [email protected] Nationwide Children’s Hospital, Columbus, Ohio More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003282AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "How Safe Is the Use of Intradetrusor OnabotulinumtoxinA in Children?." The Journal of Urology, 209(4), pp. 663–664 REFERENCES 1. . Bladder reconstruction rates differ among centers participating in National Spina Bifida Patient Registry. J Urol. 2018; 199(1):268-273. Link, Google Scholar 2. . Complications of complex lower urinary tract reconstruction in patient with neurogenic versus nonneurogenic bladder—is there a difference?. J Urol. 2008; 180(6):2629-2634. Link, Google Scholar 3. Impact of body mass index on 30-day postoperative morbidity in pediatric and adolescent patients undergoing continence urinary tract reconstruction. J Pediatr Urol. 2019; 14(4):521.e1-521.e7. Crossref, Google Scholar 4. . Bladder continent catheterizable conduit (the Mitrofanoff procedure): long-term issues that should not be underestimated. J Pediatr Surg. 2017; 52(3):469-472. Crossref, Medline, Google Scholar 5. . Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele. J Urol. 1994; 152(5 Pt 1):1582-1585. Link, Google Scholar 6. . Intraoperative onabotulinumtoxin-A reduces postoperative narcotic and anticholinergic requirements after continent bladder reconstruction. Urology. 2018; 118:183-188. Crossref, Medline, Google Scholar 7. . Feasibility of awake intravesical botulinum toxin injection in pediatric neurogenic bladder. J Urol. 2022; 208(33):702-710. Link, Google Scholar 8. . The use of botulinum toxin for the treatment of overactive bladder syndrome. Indian J Urol. 2013; 29(1):2-11. Crossref, Medline, Google Scholar 9. . Long-term safety and tolerability of repeated treatments with onabotulinumtoxinA in children with neurogenic detrusor overactivity. J Urol. 2023; 209(4):774-784. Link, Google Scholar 10. Renal consequences of intradetrusor botulinum toxin A in the treatment of pediatric neurogenic bladder. Poster presented at: Society for Pediatric Urology meeting at American Urological Association annual meeting; May 3-6, 2019; Chicago, IL. Google Scholar Support: None. Conflict of Interest: The Author has no conflict of interest to report. Ethics Statement: This study received Institutional Review Board approval (IRB16-00249). © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue 4April 2023Page: 663-664 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Christina B. Ching Nationwide Children’s Hospital, Columbus, Ohio *Correspondence: Nationwide Children’s Hospital, 700 Children’s Hospital Dr, Columbus, OH 43205 telephone: 614-722-6630; E-mail Address: [email protected] More articles by this author Expand All Support: None. Conflict of Interest: The Author has no conflict of interest to report. Ethics Statement: This study received Institutional Review Board approval (IRB16-00249). Advertisement PDF downloadLoading ...